Bayer will be revealing limited details about an innovative forthcoming turf fungicide at this year’s STRI research event (17-18 September 2014), along with offering an insight into their research and development process for bringing products to market.
“Visitors to the STRI event will have the opportunity to see some of our work and gain an insight into the research that is carried out to develop a new product,” notes Bayer’s Colin Mumford. “The process of bringing each new product to market can include the analysis of up to 100,000 potential active substances, extensive trialling and around £300 million.”
Currently in the final stages of the regulatory approval process, the upcoming fungicide uses the latest in StressGard™ Formulation Technology and introduces a whole new active ingredient class to the sports turf sector.
Colin comments, “This technology is the culmination of 15 years of research and development. It has been proven to be both effective and reliable in enhancing disease management and stress reduction, to improve playability and performance within Bayer’s existing fungicide product, Interface®.”The trials showcased at the STRI research event represent Bayer’s vision for the future of fungicides; reduced chemical inputs and the introduction of new solutions, within an integrated approach to control and improving sustainability.
“We aim to provide Turf Managers with solutions to maximise disease control, whilst at the same time minimising the risk of disease resistance,” adds Colin. “Ensuring our products have little or no impact on the environment is also a key driver of our product development. “We are a strong advocate for integrated disease control programmes and firmly believe that this approach is key in addressing resistance issues and for the wider future of turf management,” Colin concludes.
Click here to find out more about StressGard™ Formulation Technology.
INTERFACE® contains 256g/L iprodione and 16g/L trifloxystrobin. USE PLANT PROTECTION PRODUCTS SAFELY. ALWAYS READ THE LABEL AND PRODUCT INFORMATION BEFORE USE. PAY ATTENTION TO THE RISK INDICATIONS AND FOLLOW THE SAFETY PRECAUTIONS ON THE LABEL. TRIPLE RINSE CONTAINERS AT THE TIME OF USE, PUNCTURE AND INVERT TO DRY (MAPP 16060) (PCS 04882)